The FDA’s Division of Drug Marketing, Advertising and Communications has issued untitled letters of violation to Schering-Plough for its Nasonex nasal spray, and to GlaxoSmithKline for its Flonase ...

In an April trial Apotex claimed that its spray differs because it will not contain water, Reuters says. With sales just shy of $1.3 billion in 2011, Nasonex allergy spray is Merck's ...

Merck, Sharp & Dohme Corp. has filed a second suit to halt plans by Apotex Inc. for a generic version of Merck's popular nasal spray, Nasonex, after the company's previous patent infringement suit in ...

June 15 (Reuters) - Merck & Co, Inc lost a patent infringement lawsuit against Apotex Inc on Friday over Apotex's plans to market a generic version of the nasal allergy spray Nasonex. Sign up here.

Last week, on Friday, June 15, 2012, Merck (NYSE: MRK) announced the U.S. District Court for the District of New Jersey (Judge Peter G. Sheridan) ruled against the company on the issue of patent ...

Merck Sharp & Dohme has won an injunction in Australia preventing generic rival Apotex from selling a range of nasal sprays alleged to infringe the IP rights in Merck’s Nasonex product The order comes ...

Pharma major Aurobindo Pharma Limited on Tuesday informed the bourses that it has bagged final approval from the US Food & Drug Administration (USFDA) to manufacture and market Mometasone Furoate ...

The appointment marks McCann Hong Kong's first health care account. This is also the first time MSD has engaged an advertising agency to market this brand. The creative pitch, which took place in July ...

DUBLIN, March 17, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Quality, Affordable Self-Care Products, today announced that it has received final approval from the U.S.

Credit: Getty Images. This is the first OTC formulation for Nasonex and is expected to be available later this year. The Food and Drug Administration (FDA) has approved the prescription to ...